Clinical Trial Update: Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC [NA]

View source ↗

Summary

A clinical trial is evaluating Cadonilimab in combination with Fruquintinib and SBRT as third- or later-line therapy for microsatellite-stable metastatic colore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cadonilimab
• Fruquintinib (fruquintinib)

Snippet

Sponsor: Liu Huang | Conditions: Metastatic Colorectal Cancer | NA | Status: RECRUITING